Peak Pharmaceuticals (OTCMKTS:PKPH) Shares Down 0.6% – Here’s What Happened

Shares of Peak Pharmaceuticals, Inc. (OTCMKTS:PKPHGet Free Report) dropped 0.6% during mid-day trading on Wednesday . The company traded as low as $0.8548 and last traded at $0.8548. Approximately 101 shares changed hands during mid-day trading, a decline of 99% from the average daily volume of 9,053 shares. The stock had previously closed at $0.8603.

Peak Pharmaceuticals Trading Down 0.6%

The firm has a fifty day moving average of $1.01 and a 200 day moving average of $1.66.

Peak Pharmaceuticals Company Profile

(Get Free Report)

Peak Pharmaceuticals, Inc manufactures and markets pharmaceutical level products containing phytocannabinoids, an abundant and pharmaceutically active component of industrial hemp for the prevention and alleviation of various conditions and diseases. The company was founded on December 18, 2007 and is headquartered in Scottsdale, AZ.

Featured Articles

Receive News & Ratings for Peak Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Peak Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.